Tonix Pharmaceuticals Holding Corp.
TNXP
$15.52
$0.301.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 64.66% | -17.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 64.66% | -17.74% | |||
| Cost of Revenue | -58.22% | 246.98% | |||
| Gross Profit | 250.94% | -185.73% | |||
| SG&A Expenses | 58.63% | 60.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.01% | 63.90% | |||
| Operating Income | -16.86% | -76.26% | |||
| Income Before Tax | -13.22% | -68.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.22% | -68.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.22% | -68.00% | |||
| EBIT | -16.86% | -76.26% | |||
| EBITDA | -17.23% | -78.74% | |||
| EPS Basic | 7.03% | -35.90% | |||
| Normalized Basic EPS | 7.02% | -55.18% | |||
| EPS Diluted | 7.03% | -35.90% | |||
| Normalized Diluted EPS | 7.02% | -55.18% | |||
| Average Basic Shares Outstanding | 21.77% | 23.62% | |||
| Average Diluted Shares Outstanding | 21.77% | 23.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||